S. Sizemore

Publications45
h-index13
Citations687
Highly Influential Citations34
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • C. Perou
  • 591 Publications • 123,659 Citations
  • R. Keri
  • 100 Publications • 3,531 Citations
  • I. Ellis
  • 1,158 Publications • 62,186 Citations
  • M. Ostrowski
  • 227 Publications • 11,099 Citations
  • Publications
  • Influence
Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin.
Podocalyxin is an anti-adhesive transmembrane sialomucin that has been implicated in the development of more aggressive forms of breast and prostate cancer. The mechanism through which podocalyxin… Expand
  • 112
  • 11
  • PDF
FOXA1 Represses the Molecular Phenotype of Basal Breast Cancer Cells
Breast cancer is a heterogeneous disease that comprises multiple subtypes. Luminal subtype tumors confer a more favorable patient prognosis, which is, in part, attributed to estrogen receptor (ER)-α… Expand
  • 112
  • 8
The Forkhead Box Transcription Factor FOXC1 Promotes Breast Cancer Invasion by Inducing Matrix Metalloprotease 7 (MMP7) Expression*
Background: FOXC1 is associated with breast cancer aggressiveness and the basal-like breast cancer subtype but the mechanism through which FOXC1 increases aggressiveness has not been elucidated.… Expand
  • 82
  • 3
Cloning and Characterization of scon-3+, a New Member of the Neurospora crassa Sulfur Regulatory System
ABSTRACT The sulfur regulatory system of Neurospora crassa consists of a group of sulfur-regulated structural genes (e.g., arylsulfatase) that are under coordinate control of the CYS3 positive… Expand
  • 19
  • 3
  • PDF
Stromal PDGFR-α Activation Enhances Matrix Stiffness, Impedes Mammary Ductal Development, and Accelerates Tumor Growth
The extracellular matrix (ECM) is critical for mammary ductal development and differentiation, but how mammary fibroblasts regulate ECM remodeling remains to be elucidated. Herein, we used a mouse… Expand
  • 23
  • 2
Changes in BAI1 and Nestin Expression Are Prognostic Indicators for Survival and Metastases in Breast Cancer and Provide Opportunities for Dual Targeted Therapies
The 2-year survival rate of patients with breast cancer brain metastases is less than 2%. Treatment options for breast cancer brain metastases are limited, and there is an unmet need to identify… Expand
  • 16
  • 2
  • PDF
Loss of Breast Cancer Metastasis Suppressor 1 Protein Expression Predicts Reduced Disease-Free Survival in Subsets of Breast Cancer Patients
Purpose: This study aims to determine the effect of loss of breast cancer metastasis suppressor 1 (BRMS1) protein expression on disease-free survival in breast cancer patients stratified by estrogen… Expand
  • 91
  • 1
  • PDF
Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors.
Triple-negative breast cancers (TNBC) are highly aggressive, lack FDA-approved targeted therapies, and frequently recur, making the discovery of novel therapeutic targets for this disease imperative.… Expand
  • 13
  • 1
Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1
This corrects the article DOI: 10.1038/onc.2016.383
  • 13
  • 1
Stromal Platelet–Derived Growth Factor Receptor-β Signaling Promotes Breast Cancer Metastasis in the Brain
This study reveal a previously unknown role for PDGFB-to-PDGFRβ paracrine signaling in the promotion of breast cancer brain metastases and support the prognostic and therapeutic clinical utility of… Expand
  • 3
  • 1
...
1
2
3
4
5
...